Aiko Nagayama

733 total citations
27 papers, 394 citations indexed

About

Aiko Nagayama is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aiko Nagayama has authored 27 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aiko Nagayama's work include HER2/EGFR in Cancer Research (13 papers), Cancer Treatment and Pharmacology (9 papers) and Breast Cancer Treatment Studies (9 papers). Aiko Nagayama is often cited by papers focused on HER2/EGFR in Cancer Research (13 papers), Cancer Treatment and Pharmacology (9 papers) and Breast Cancer Treatment Studies (9 papers). Aiko Nagayama collaborates with scholars based in Japan, United States and United Kingdom. Aiko Nagayama's co-authors include Aditya Bardia, Leif W. Ellisen, Neelima Vidula, Bruce A. Chabner, Tomoko Seki, Maiko Takahashi, Tetsu Hayashida, Yuko Kitagawa, Hiromitsu Jinno and Akiko Matsumoto and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Annals of Oncology.

In The Last Decade

Aiko Nagayama

22 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aiko Nagayama Japan 9 274 100 97 92 74 27 394
Ron Korn United States 8 206 0.8× 83 0.8× 71 0.7× 68 0.7× 104 1.4× 26 350
Shih‐Hung Yang Taiwan 11 286 1.0× 128 1.3× 70 0.7× 60 0.7× 114 1.5× 37 412
Coralie Moncharmont France 9 204 0.7× 83 0.8× 59 0.6× 160 1.7× 157 2.1× 26 437
Ruiping Zhai China 13 169 0.6× 61 0.6× 117 1.2× 78 0.8× 146 2.0× 28 468
Céline Le Gall France 6 339 1.2× 80 0.8× 144 1.5× 99 1.1× 151 2.0× 6 450
Li-Na Zhou China 10 191 0.7× 63 0.6× 47 0.5× 70 0.8× 202 2.7× 20 405
Elena García-García Spain 7 337 1.2× 100 1.0× 43 0.4× 117 1.3× 121 1.6× 13 431
Mohamed M. Kahila United States 7 205 0.7× 121 1.2× 49 0.5× 65 0.7× 126 1.7× 15 373
Julia K. L. Woodward United Kingdom 12 233 0.9× 67 0.7× 78 0.8× 76 0.8× 191 2.6× 14 415

Countries citing papers authored by Aiko Nagayama

Since Specialization
Citations

This map shows the geographic impact of Aiko Nagayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiko Nagayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiko Nagayama more than expected).

Fields of papers citing papers by Aiko Nagayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiko Nagayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiko Nagayama. The network helps show where Aiko Nagayama may publish in the future.

Co-authorship network of co-authors of Aiko Nagayama

This figure shows the co-authorship network connecting the top 25 collaborators of Aiko Nagayama. A scholar is included among the top collaborators of Aiko Nagayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiko Nagayama. Aiko Nagayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masuda, Kenta, Yusuke Kobayashi, Tomoko Seki, et al.. (2025). Current Situation and Future Directions of Risk-reducing Salpingo-oophorectomy. The Keio Journal of Medicine. 74(3). 138–145.
2.
Seki, Tomoko, Yusuke Kobayashi, Kenta Masuda, et al.. (2025). Exploring Breast Cancer Risk Management in HBOC Patients: Image Surveillance Versus Risk-reducing Surgery. The Keio Journal of Medicine. 74(3). 130–137.
3.
Takahashi, Kaori, Ryuji Uozumi, Toru Mukohara, et al.. (2024). Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer. The Oncologist. 29(6). e741–e749. 6 indexed citations
4.
Kawai, Yuko, Aiko Nagayama, Makoto Takeuchi, et al.. (2024). A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer. Breast Cancer. 32(1). 120–131. 2 indexed citations
5.
Wu, Bogang, Sheng Sun, Aiko Nagayama, et al.. (2023). Abstract 1696: Systematic identification of pathways associated with antibody drug conjugate sensitivity in breast cancer. Cancer Research. 83(7_Supplement). 1696–1696.
6.
Hayashida, Tetsu, Aiko Nagayama, Tomoko Seki, et al.. (2022). Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system. Cancer Science. 113(5). 1722–1730. 8 indexed citations
7.
Shimomura, Akihiko, Masayuki Yoshida, Takashi Kubo, et al.. (2022). Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer. Breast Cancer Research and Treatment. 197(3). 593–602.
8.
Hayashida, Tetsu, Shigeo Yamaguchi, Yuko Kawai, et al.. (2021). Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development. Breast Cancer Research and Treatment. 186(2). 353–361. 3 indexed citations
9.
Hayashida, Tetsu, Takeshi Murata, Aiko Nagayama, et al.. (2021). A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin. Breast Cancer. 28(4). 884–895. 7 indexed citations
10.
Nagayama, Aiko, Neelima Vidula, & Aditya Bardia. (2021). Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates. PubMed. 35(3505). 249–254. 21 indexed citations
11.
Hayashida, Tetsu, Yuko Kawai, Aiko Nagayama, et al.. (2020). Abstract P1-02-09: Diagnostic system of breast ultrasound images using Convolutional Neural Network. Cancer Research. 80(4_Supplement). P1–2. 2 indexed citations
12.
Matsui, Akira, Yuya Murata, Norikazu Masuda, et al.. (2019). Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study. Oncotarget. 10(55). 5680–5689. 5 indexed citations
13.
Hayashida, Tetsu, Aiko Nagayama, Tomoko Seki, et al.. (2018). Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis. The Oncologist. 24(6). e347–e357. 31 indexed citations
14.
Hayashida, Tetsu, Hiromitsu Jinno, Hiroki Sato, et al.. (2018). Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial. BMC Cancer. 18(1). 701–701. 13 indexed citations
15.
Zangardi, Mark L., Laura M. Spring, Aiko Nagayama, & Aditya Bardia. (2018). Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?. Expert Opinion on Investigational Drugs. 28(2). 107–112. 8 indexed citations
16.
Matsui, Akira, Noriyuki Suzuki, Masaru Hirata, et al.. (2017). Evaluation of Efficacy and Safety of Upfront Weekly Nanoparticle Albumin-bound Paclitaxel for HER2-negative Breast Cancer. Anticancer Research. 37(11). 6481–6488. 2 indexed citations
17.
Hayashida, Tetsu, Aiko Nagayama, Tomoko Seki, et al.. (2017). The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer. Cancer Treatment Reviews. 62. 9–17. 19 indexed citations
18.
Nagayama, Aiko, Akira Matsui, M. Hirata, et al.. (2016). Evaluation of neoadjuvant weekly nanoparticle albumin-bound paclitaxel for HER2-negative breast cancer. Annals of Oncology. 27. vi92–vi92. 2 indexed citations
19.
Nagayama, Aiko, Hiroko Tokunaga, Matsujiro Ishibashi, et al.. (2015). Nucleoside Diphosphate Kinase from Psychrophilic Pseudoalteromonas sp. AS-131 Isolated from Antarctic Ocean. The Protein Journal. 34(4). 275–283. 3 indexed citations
20.
Nagayama, Aiko, Tetsu Hayashida, Hiromitsu Jinno, et al.. (2014). Comparative Effectiveness of Neoadjuvant Therapy for HER2–Positive Breast Cancer: A Network Meta-Analysis. JNCI Journal of the National Cancer Institute. 106(9). 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ron Korn Breakdown of academic impact, for papers by Shih‐Hung Yang Breakdown of academic impact, for papers by Coralie Moncharmont Breakdown of academic impact, for papers by Ruiping Zhai Breakdown of academic impact, for papers by Céline Le Gall Breakdown of academic impact, for papers by Li-Na Zhou Breakdown of academic impact, for papers by Elena García-García Breakdown of academic impact, for papers by Mohamed M. Kahila Breakdown of academic impact, for papers by Julia K. L. Woodward
Rankless by CCL
2026